Results 1 to 10 of about 66,247 (269)

Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Myocardial revascularization has been advocated to improve myocardial function and prognosis in ischemic cardiomyopathy (ICM). We discuss the evidence for revascularization in patients with ICM and the role of ischemia and viability detection ...
Riccardo Liga, Andrea Colli, David P. Taggart, William E. Boden, Raffaele De Caterina   +4 more
doaj   +2 more sources

Investigation of Platelet Apoptosis in Patients after Surgical Myocardial Revascularization [PDF]

Biomedicines, 2023
Platelets are one of the main participants in vascular accidents in cases of coronary heart disease (CHD). In this study, we sought to detect platelet apoptosis in patients with coronary artery disease who underwent scheduled myocardial revascularization
Alisa A. Sokolovskaya, Mikhail A. Popov, Ekaterina A. Sergeeva, Arkadiy A. Metelkin, Dmitry I. Zybin, Dmitry V. Shumakov, Aslan A. Kubatiev   +6 more
doaj   +2 more sources

Exercise-based cardiac rehabilitation after myocardial revascularization: a systematic review and meta-analysis [PDF]

Reviews in Cardiovascular Medicine, 2022
Background: The present study aimed to analyze the effects of exercise-based cardiac rehabilitation (CR) on physical performance after myocardial revascularization.
Helton Oliveira Campos, Quézia Teixeira Rodrigues, Lucas Rios Drummond, Paulo Marcelo Andrade Lima, Mateus da Costa Monteiro, Samuel Penna Wanner, Cândido Celso Coimbra   +6 more
doaj   +1 more source

Endovascular myocardial revascularization in patients with multivessel coronary artery disease with chronic total occlusion and high surgical risk

Кардиоваскулярная терапия и профилактика, 2020
The main reason  for incomplete myocardial revascularization is the presence of chronic coronary total occlusion (CTO), which is detected in every fourth patient during coronary angiography.
D. K. Vasiliev, B. A. Rudenko, A. S. Shanoyan, F. B. Shukurov, D. A. Feshchenko   +4 more
doaj   +1 more source

Complete percutaneous myocardial revascularization in patients with STEMI complicated by cardiogenic shock [PDF]

Vojnosanitetski Pregled, 2019
Background/Aim. Despite considerable progress in terms of early myocardial revascularization and the use of mechanical circulatory support, cardiogenic shock continues to be the leading cause of death in acute myocardial infarction.
Petrović Milovan, Jaraković Milana, Čanković Milenko, Srdanović Ilija, Kovačević Mila, Tešić Dragica, Ivanović Vladimir, Redžek Aleksandar, Velicki Lazar   +8 more
doaj   +1 more source

Comparative Analysis of Early Postoperative Period in Patients with Total Arterial Revascularization and Conventional Coronary Artery Bypass Grafting

Український журнал серцево-судинної хірургії, 2022
The use of total arterial myocardial revascularization in patients with multivessel lesions of the coronary arteries has a number of advantages, namely the duration of functioning or patency of the grafts.
Nadiya M. Rudenko, Oleksandr Yu. Pukas
doaj   +1 more source

Coronary Computed Tomography Angiography Compared With Single Photon Emission Computed Tomography Myocardial Perfusion Imaging as a Guide to Optimal Medical Therapy in Patients Presenting With Stable Angina: The RESCUE Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background The RESCUE (Randomized Evaluation of Patients with Stable Angina Comparing Utilization of Noninvasive Examinations) trial was a randomized, controlled, multicenter, comparative efficacy outcomes trial designed to assess whether initial testing
Arthur E. Stillman, Constantine Gatsonis, Joao A.C. Lima, Tao Liu, Bradley S. Snyder, Jean Cormack, Vinay Malholtra, Mitchell D. Schnall, James E. Udelson, Udo Hoffmann, Pamela K. Woodard   +10 more
doaj   +1 more source

Complete Revascularization by Percutaneous Coronary Intervention for Patients With ST‐Segment–Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: An Updated Meta‐Analysis of Randomized Trials

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background For patients with ST‐segment–elevation myocardial infarction (STEMI) and multivessel coronary artery disease, the optimal treatment of the non‐infarct‐related artery has been controversial.
Yousif Ahmad, James P. Howard, Ahran Arnold, Megha Prasad, Henry Seligman, Christopher M. Cook, Takayuki Warisawa, Matthew Shun‐Shun, Ziad Ali, Manish A. Parikh, Rasha Al‐Lamee, Sayan Sen, Darrel Francis, Jeffrey W. Moses, Martin B. Leon, Gregg W. Stone, Dimitri Karmpaliotis   +16 more
doaj   +1 more source

Risk factors for acute myocardial infarction during the postoperative period of myocardial revascularization

Arquivos Brasileiros de Cardiologia, 2003
OBJECTIVE: To identify risk factors for acute myocardial infarction during the postoperative period after myocardial revascularization. METHODS: This was a case-control study paired for sex, age, number, type of graft used, coronary endarterectomy, type ...
José Ribamar Costa Jr., Dinaldo C. Oliveira, Alexei DerBedrossian, Enilton T. Egito, Edson R. Romano, Marcos O. Barbosa, Ieda M. Liguori, Jorge Fahran, Luis C. B. Souza, Adib D. Jatene, Leopoldo S. Piegas   +10 more
doaj   +1 more source

Myocardial Viability Testing in the Management of Ischemic Heart Failure

Life, 2022
Although major advances have occurred lately in medical therapy, ischemic heart failure remains an important cause of death and disability. Viable myocardium represents a cause of reversible ischemic left ventricular dysfunction.
Elena Emilia Babes, Delia Mirela Tit, Alexa Florina Bungau, Cristiana Bustea, Marius Rus, Simona Gabriela Bungau, Victor Vlad Babes   +6 more
doaj   +1 more source